Search details
1.
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
Proc Natl Acad Sci U S A
; 116(36): 17990-18000, 2019 09 03.
Article
in English
| MEDLINE | ID: mdl-31439820
2.
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer.
Breast Cancer Res
; 22(1): 87, 2020 08 12.
Article
in English
| MEDLINE | ID: mdl-32787886
3.
Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells.
Mol Cell Proteomics
; 17(6): 1170-1183, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29463595
4.
Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report.
BMC Urol
; 20(1): 171, 2020 Oct 28.
Article
in English
| MEDLINE | ID: mdl-33115461
5.
P53: A Guardian of Immunity Becomes Its Saboteur through Mutation.
Int J Mol Sci
; 21(10)2020 May 13.
Article
in English
| MEDLINE | ID: mdl-32414156
6.
A quantitative model to predict pathogenicity of missense variants in the TP53 gene.
Hum Mutat
; 40(6): 788-800, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30840781
7.
E6AP goes viral: the role of E6AP in viral- and non-viral-related cancers.
Carcinogenesis
; 40(6): 707-714, 2019 07 06.
Article
in English
| MEDLINE | ID: mdl-31087000
8.
An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy.
Int J Cancer
; 144(5): 1151-1159, 2019 03 01.
Article
in English
| MEDLINE | ID: mdl-30288742
9.
Exploring the oncoproteomic response of human prostate cancer to therapeutic radiation using data-independent acquisition (DIA) mass spectrometry.
Prostate
; 78(8): 563-575, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29520850
10.
MDM4 is a rational target for treating breast cancers with mutant p53.
J Pathol
; 241(5): 661-670, 2017 04.
Article
in English
| MEDLINE | ID: mdl-28097652
11.
Biodosimetric transcriptional and proteomic changes are conserved in irradiated human tissue.
Radiat Environ Biophys
; 57(3): 241-249, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-29850926
12.
Ubiquitin ligase E6AP mediates nonproteolytic polyubiquitylation of ß-catenin independent of the E6 oncoprotein.
J Gen Virol
; 97(12): 3313-3330, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27902311
13.
APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma.
Gut
; 64(10): 1506-16, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26187504
14.
The p53-Mdm2 loop: a critical juncture of stress response.
Subcell Biochem
; 85: 161-86, 2014.
Article
in English
| MEDLINE | ID: mdl-25201194
15.
E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.
Blood
; 120(4): 822-32, 2012 Jul 26.
Article
in English
| MEDLINE | ID: mdl-22689861
16.
c-Abl phosphorylates E6AP and regulates its E3 ubiquitin ligase activity.
Biochemistry
; 52(18): 3119-29, 2013 May 07.
Article
in English
| MEDLINE | ID: mdl-23581475
17.
Establishing the Link between X-Chromosome Aberrations and TP53 Status, with Breast Cancer Patient Outcomes.
Cells
; 12(18)2023 09 11.
Article
in English
| MEDLINE | ID: mdl-37759468
18.
MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation.
J Cell Sci
; 123(Pt 14): 2423-33, 2010 Jul 15.
Article
in English
| MEDLINE | ID: mdl-20571051
19.
Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer.
Biochem J
; 436(2): 481-91, 2011 Jun 01.
Article
in English
| MEDLINE | ID: mdl-21426304
20.
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss.
Cell Death Dis
; 13(9): 777, 2022 09 08.
Article
in English
| MEDLINE | ID: mdl-36075907